FDA Inspection 618646 - Novo Nordisk Pharmaceutical Industries LP - September 02, 2009

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novo Nordisk Pharmaceutical Industries LP

Record Details

This FDA Inspection record concerns Novo Nordisk Pharmaceutical Industries LP, with an inspection on September 2, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Novo Nordisk Pharmaceutical Industries LP
Inspection Date: September 2, 2009
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · d4a23119-3ded-419a-a3ad-d626e8acd7e4

Violation Codes10

21 CFR 211.110(a)21 CFR 211.160(a)21 CFR 211.167(a)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.42(a)21 CFR 211.42(b)21 CFR 211.42(c)21 CFR 211.63

Full citation text and observation details available on the Dashboard.